The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dekaris, I.
Right arrow Articles by Dana, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dekaris, I.
Right arrow Articles by Dana, M. R.
The Journal of Immunology, 1999, 162: 4235-4239.
Copyright © 1999 by The American Association of Immunologists

TNF-{alpha} Regulates Corneal Langerhans Cell Migration1

Iva Dekaris, Su-Ning Zhu and M. Reza Dana2

Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Langerhans cells (LC) belong to the dendritic cell family and mediate Ag presentation in the cornea and ocular surface. Under normal physiological conditions, the central cornea is devoid of LC. Centripetal migration of LC plays a critical role in promoting immunoinflammatory responses in the eye including allograft rejection and herpetic keratitis. The molecular mechanisms responsible for ocular LC migration are poorly understood. To examine whether TNF-{alpha} mediates corneal LC migration and to establish the interaction of IL-1 and TNF-{alpha} in regulating LC migratory capacity, we utilized gene-targeted knockout mice lacking IL-1 receptor I (IL-1RI-/-), TNF receptor I (p55-/-), TNF receptor II (p75-/-), or both (p55-/-p75-/-). LC migration was induced by thermal cautery or cytokine injection and enumerated by an immunofluorescence assay. Migration of LC after cauterization and TNF-{alpha} injection was significantly depressed in both p55-/- and p75-/- mice. Similarly, in the first 72 h after intracorneal injection of IL-1{alpha}, LC migration was reduced in p55-/-, p75-/-, and p55-/-p75-/- mice. In contrast, injection of TNF-{alpha} in IL-1RI-/- mice led to normal migration of corneal LC indistinguishable from wild-type controls. These results suggest that the IL-1 induction of corneal LC migration is largely mediated by TNFR function, whereas TNF-{alpha} induction of LC migration is independent of IL-1RI activity. Moreover, the data suggest that both p55 and p75 signaling pathways are important in mediating LC migration in the cornea.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Epidermal Langerhans cells (LC)3 were originally described by Paul Langerhans in 1868 (1), while the presence of histologically similar cells in the ocular surface was reported even earlier by Engelmann (2). Corneal LC are bone marrow-derived cells that are thought to represent the professional APCs of the ocular surface and hence are capable of activating T cells and initiating ocular immune responses (3, 4). While they are physiologically absent from the central cornea, a number of corneal stimuli (e.g., trauma, infection, cauterization) can induce centripetal migration of LC into the cornea from the limbus, the border between cornea and conjunctiva, where they may initiate Ag processing (5, 6, 7, 8).

In the setting of corneal transplantation, the presence of LC in the donor cornea has been shown to effect host allosensitization and graft rejection (9). Since in clinical corneal transplantation patients receive central corneal buttons devoid of LC, it is believed that corneal allografts may instead be recognized through the "indirect" pathway of allorecognition involving activation and migration of recipient LC from the limbus to the donor corneal tissue where they can acquire foreign Ag (10, 11). Two lines of indirect evidence suggest that LC migration is a critical element in host allosensitization. First, the number of infiltrating host LC in the graft bed is predictive of the swiftness with which the host acquires donor-specific delayed type hypersensitivity (12), and the promotion of corneal allograft survival by IL-1 receptor antagonist (IL-1ra) has been correlated with suppression of LC migratory capacity (13). Beyond these observations in experimental models of corneal transplantation, migration of limbal LC into the cornea has been associated with loss of ocular immune privilege (14) and other immunoinflammatory events in the cornea such as development of herpetic keratitis (8, 15, 16, 17, 18, 19).

The mechanisms involved in regulation of corneal LC migration are incompletely understood. Several cytokines have been implicated but only the role of IL-1 has been extensively studied (9, 14, 20, 21). However, the close cross-regulation of IL-1 and TNF-{alpha} in multiple models of inflammation, and the fact that stimulation of central corneal tissue results not only in IL-1 but also in TNF-{alpha} expression from resident epithelial cells (22) makes TNF-{alpha} a candidate for study in regulation of corneal LC migration. Moreover, it has recently been shown that TNF-{alpha} plays a role in the migration of dendritic cells in the skin (23, 24, 25).

TNF-{alpha} is a pleiotropic cytokine that mediates a large number of proinflammatory functions such as up-regulation in the expression of adhesion and costimulatory molecules, neutrophil activation, induction of chemokine secretion and activation of the NF-{kappa}B signal transduction pathway (26, 27). TNF-{alpha} activity is regulated by two distinct receptors, the type I receptor (p55) and the type II receptor (p75), which have largely homologous extracellular domains but distinct intracellular domains that can mediate discrete cellular responses (28, 29). To determine whether the genetic deficiency of either, or both, TNF receptors could affect corneal LC migration, mutant mice were exposed to different corneal stimuli that efficiently induce LC migration in wild-type mice. Furthermore, experiments were conducted to determine whether the well-known induction of LC migration by IL-1 is, at least in part, mediated by TNF-{alpha}. Our results suggest that the signaling pathways of both TNF receptors are important in mediating corneal LC migration. These data also suggest that IL-1 induction of LC migration is largely mediated by TNF-{alpha} receptor activity and, conversely, that TNF-{alpha} can activate corneal LC migration independently of IL-1.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice and anesthesia

Male mice 6 to 8 wk old with homozygous genetic deficiency of either one TNF-{alpha} receptor (TNFRI-KO (p55-/-), TNFRII-KO (p75-/-)), both TNF-{alpha} receptors (double TNFR-KO (p55-/-p75-/-)), or the IL-1 receptor I (IL-1RI-KO (IL-1RI-/-)) and their wild-type controls (C57BL.129 for p55-/- and p55-/-p75-/-; and C57BL/6 for p75-/- and IL-1RI-/-) were bred in the Schepens Eye Research Institute Animal Colony. Breeder pairs of knockout (KO) animals were provided as follows: TNFRI-KO (p55-/-) and double TNFR-KO (p55-/-p75-/-) mice by F. Hoffmann-La Roche AG, Basel, Switzerland; TNFRII-KO (p75-/-) mice by Genentech, San Francisco, CA. All animals were treated according to the Statement for the Use of Animals in Ophthalmic and Vision Research by the Association for Research in Vision and Ophthalmology. Each animal was anesthetized with an intramuscular injection of 3–4 mg of ketamine and 0.1 mg of xylazine before surgical procedures. Each protocol at each time point was performed on 10 murine corneas and replicated once; representative data are presented herein.

Thermal cautery of the corneal surface and intracorneal cytokine injections

Mice were anesthetized and placed under the operating microscope. Using the tip of a hand-held cautery, five burns were applied to the central 50% of the cornea to induce centripetal LC migration (6). Erythromycin ophthalmic ointment was applied immediately following surgery. Two weeks after cauterization, which correlates with the maximal LC migration response in this model (14), corneas were harvested and LC enumeration was performed as detailed below. For cytokine injections, a microsurgical blade (Superblade 30°, Kabi Pharmacia Ophthalmic Inc, Franklin, OH) was used to make a horizontal 50% thickness intrastromal incision in the central cornea. After forming a tunnel in the stromal tissue, cytokine was injected by use of a 33-gauge needle (Delasco, Tokyo, Japan). Recombinant murine IL-1{alpha} (1 ng, R&D Systems, Minneapolis, MN) or recombinant murine TNF-{alpha} (10 pg–1 ng, R&D Systems) were injected. Endotoxin levels were <0.1 ng/µg of recombinant cytokine for all samples by Limulus amoebocyte lysate assay. Cytokine preparations were diluted in PBS to achieve the desired dose in a 1-µl injection; and controls received intracorneal injections of 1% PBS alone. In addition, to ensure that the induction of LC was cytokine specific and not due to potential endotoxin contamination, additional controls included injections of heat-inactivated (15 min at 100°C) TNF-{alpha} and IL-1{alpha} cytokine preparations into wild-type controls (n = 5 per strain). At specified time points, corneas were harvested and LC enumeration was performed as described below.

Langerhans cells enumeration

LC were enumerated in whole corneal epithelial sheets by use of indirect immunofluorescence assay, as described previously (14). Briefly, at 24 h, 72 h, and 1 and 2 wk following corneal stimulation (cautery or intracorneal cytokine injection), murine eyes were collected and the corneas were dissected. Corneas were placed in 20 mM EDTA buffer and incubated for 30–40 min at 37°C. The epithelium was detached and washed in PBS at room temperature. Epithelial sheets were fixed with 95% alcohol for 30 min. After two washings in PBS for 10 min, epithelial sheets were incubated with 1/15 diluted primary anti-murine Iab Ab for 45 min at 37°C. Controls bypassed this step or were incubated with an unrelated (e.g., anti-Iad) Ab as previously described (14). Epithelial sheets were washed twice in PBS for 10 min and incubated with 1/10 diluted fluorescein isothiocyanate-labeled goat anti-mouse secondary Ab for 30 min at 37°C (PharMingen, San Diego, CA). Samples were mounted on slides and immediately examined under the fluorescent microscope. Langerhans cells were then enumerated using a square ocular grid.

Statistical analysis

Comparison of the mean number of LC between different mouse strains, as well as between treatment protocols, was made using the Student’s t test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Migration of LC following corneal stimulation in TNF receptor-deficient mice

To determine whether TNF receptor activity could influence LC migration into the cornea, 1 ng of TNF-{alpha} was injected into the corneal center of wild-type and TNFR-KO mice. In companion experiments, thermal cautery was applied to murine corneas to determine the role of TNFR in mediating LC migration in a standardized experimental model of corneal inflammation (6), and the number of centripetally migrated LC was determined following corneal stimulation. One week subsequent to TNF-{alpha} injection (Fig. 1Go), the number of LC in all three TNFR KO models was significantly depressed (p < 0.001) as compared with wild-type corneas, suggesting that deficiency in either p55 or p75 can profoundly attenuate the LC migratory response. Similarly after corneal cauterization, the number of central LC was significantly reduced in the absence of either TNFR-I or TNFR-II activity as compared with wild-type controls (Fig. 2GoA; p < 0.01).



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 1. LC migration is depressed after injection of TNF-{alpha} in TNFR-KO mice. LC migration into the central cornea of p55-/-, p75-/-, and p55-/-p75-/- mice, and their wild-type controls 1 wk after intrastromal injection of 1 ng of TNF-{alpha}. Wild-type mice were also injected with 1 ng of heat-inactivated cytokine as controls (data only shown for C57BL/6). Each column represents five animals. The data show that heat-inactivated cytokine does not induce LC migration and that there is significant suppression of LC migration in response to active cytokine in mice deficient in p55, p75, or both receptors (bars, SEM).

 


View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 2. Corneal and limbal LC counts after cautery stimulation are depressed in mice deficient of TNFR. LC in the central cornea (A) and limbus (B) of p55-/- and p75-/- mice and their respective wild-type controls (C57BL.129, C57BL/6) 14 days following cauterization. Each column represents 10 corneas. Normal = noncauterized corneas. The data show significant suppression of LC migration in both p55-/- and p75-/- mice (A). However, only p55-/- mice show lack of significant limbal LC accumulation after corneal stimulation (B). (*, p < 0.01 compared with wild-type controls in A, and compared with uncauterized corneas in B; bars, SEM).

 
Application of thermal cautery or active TNF-{alpha}, but not heat-inactivated cytokine, to wild-type mice not only induced migration of LC into the central cornea but also led to a significant increase in the number of recruited LC at the corneal limbus which serves as a potential reservoir for the corneal LC. However, in p55-/- animals lacking TNFR-I activity, there was only minimal increase in the LC number at the corneal limbus after stimulation (Fig. 2GoB), suggesting that TNFR-I may play a critical role in mediating LC recruitment to the limbus from the intravascular compartment after corneal stimulation.

TNF-{alpha} induction of LC migration is independent of IL-1

It has been shown that centripetal LC migration can be induced by IL-1{alpha} secretion by corneal epithelial cells or by direct injection of IL-1{alpha} into the cornea (20, 21). It is not known, however, whether TNF-{alpha} induction of LC migration is dependent on IL-1 activity. To determine whether TNF-{alpha} can induce centripetal LC migration even in the absence of IL-1 activity, different amounts of TNF-{alpha} were injected into the central cornea of IL-1RI-/- mice, and the central corneal LC were enumerated. As shown in Fig. 3Go, TNF-{alpha} was able to induce significant centripetal migration of LC in a dose-dependent manner even in the absence of IL-1RI activity, suggesting that IL-1 activation is not necessary for mediating the TNF-{alpha} effect on LC migration. Moreover, to determine whether the induction of LC migration by TNF-{alpha} is, at least in part, affected by IL-1RI activity, TNF-{alpha} was injected into IL-1RI-/- and wild-type mice, and the corneal LC were enumerated at different time points. The data demonstrate that the activity of TNF-{alpha} in promoting centripetal LC migration is identical among the two groups (Fig. 4Go), suggesting that the TNF-{alpha} effect on LC migration is independent of IL-1RI activity.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 3. TNF can induce LC migration in IL-1RI-KO mice. Centripetal LC migration 1 week following intracorneal injection of TNF-{alpha} into IL-1 receptor I-deficient (IL-1RI-/-) mice. Each column indicates 10 tested corneas. Data indicate preservation of dose-dependent TNF-{alpha} induced centripetal LC migration in animals with IL-1RI deficiency, suggesting that IL-1RI is not necessary for the TNF-{alpha} mediated effect on LC migration (*, p < 0.05 compared with control corneas; bars, SEM).

 


View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 4. TNF-{alpha} induction of LC migration is independent of IL-1RI activity. Centripetal LC migration following intracorneal injection of TNF-{alpha} (1ng) or PBS into mice with genetic deficiency of IL-1 receptor I (IL-1RI-/-) and their wild-type controls (C57BL/6). Each column indicates 10 tested corneas. The data indicate that TNF-{alpha} induction of centripetal LC migration is indistinguishable between wild-type and IL-1RI-/- mice (bars, SEM).

 
IL-1 induction of LC migration is largely mediated by TNF-{alpha}

The data above demonstrate that activation of the IL-1 system via IL-1RI is not critical for TNF-{alpha}-mediated LC migration. Therefore, to further delineate the cross-regulation between these two cytokine systems, we wanted to test the converse; namely, whether IL-1 induction of LC migration is under TNF-{alpha} regulation. A known corneal LC chemoattractant, IL-1{alpha} was injected into eyes of p55-/-, p75-/-, and p55-/-p75-/- mice. In addition, both active and heat-inactivated IL-1{alpha} was injected into the corneas of wild-type mice as controls. Heat-inactivated cytokine failed to induce LC migration (data not shown). Our data from IL-1{alpha} injection into TNFR-KO animals showed that particularly in the first 72 h, deficiency in either TNFR activity led to significant suppression of LC migration in response to cytokine as compared with wild-type controls, and this effect was most profound when both TNF receptors were depleted (Fig. 5Go). At 1 wk after stimulation, only p55-/-p75-/- (and to a lesser extent p55-/-) mice showed suppressed response to injected IL-1{alpha}. The data suggest that early induction of LC migration by IL-1 is largely under the regulation of TNF-{alpha} receptors and that combined deficiency of both TNFRs leads to a sustained suppression of IL-1-induced LC migration.



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 5. IL-1 induction of LC migration is TNFR-dependent. Centripetal LC migration at: (a) 24 h, (b) 72 h, and (c) 1 wk following intracorneal injection of IL-1{alpha} (1 ng) or PBS into p55-/-, p75-/-, and p55-/-p75-/- mice, and their wild-type controls. Control corneas left uninjected were devoid of any central LC. Each column indicates 10 corneas of each strain per time point studied. The data show significant suppression in IL-1-induced LC migration in corneas of p55-/-, p75-/-, and p55-/-p75-/- animals, particularly early after induction of LC migration, as compared with wild-type controls (*, p < 0.05 compared with respective wild-type controls; bars, SEM).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In contrast to the epidermis which is endowed with large number of LC, central regions of the cornea are devoid of LC under normal physiological conditions (30, 31, 32). Such a distribution of professional APCs is thought to play an important role in the maintenance of immune privilege in the anterior segment of the eye and likely contributes to the extraordinary success of corneal allografts (4, 6, 9, 14). Under certain conditions, however, LC can migrate centripetally and amplify immunoinflammatory responses (8, 14, 15, 16, 17, 18, 19). Because the normal cornea unlike the skin is devoid of LC but can be populated readily with these cells with appropriate stimulation (6, 7, 33), it serves as an attractive model for studying the factors that regulate LC migration.

Although the migration of LC into the central cornea appears to be an important step in initiating immune responses, the mechanisms that mediate this process remain incompletely understood. In the skin, the role of TNF-{alpha} in inducing dendritic and LC migration and cutaneous inflammation has been extensively studied. Whereas it has been demonstrated that TNF-{alpha} promotion of cutaneous inflammation is largely mediated by p55 (34), investigators have shown that TNF-{alpha} promotes migration of cutaneous dendritic cells primarily through the selective activation of p75 (23, 24). In the cornea, significant expression of TNF-{alpha} by the corneal resident cells can be induced by inflammatory stimuli (22), and the expression of a number of chemokines (e.g., RANTES, monocyte chemoattractant protein, macrophage inflammatory protein) can be under the regulation of locally produced TNF-{alpha} (35, 36, 37). The current series of experiments were performed to determine whether TNF-{alpha} activity is critical in mediating corneal LC migration.

Our data demonstrate that in the absence of functional TNF-RI or TNF-RII, the number of central LC after corneal stimulation with TNF-{alpha} or cautery are significantly lower than in wild-type controls. Moreover, because deficiency in either TNFR can so profoundly down-modulate LC migration into the central cornea in response to stimulation, the data suggest that the two receptor systems, as is seen in other models of inflammation (29), mediate largely discrete functions that in this model independently contribute to inducing LC migration. Our results also suggest that TNF-{alpha} can induce its effect on corneal LC migration in an IL-1-independent fashion. Our data show that TNF-{alpha} can induce a dose-dependent effect on corneal LC recruitment even in IL-1RI-deficient mice, suggesting that TNF-{alpha} is sufficient to induce LC migration even with a defective IL-1 system at all time points studied. Having demonstrated that the effect of TNF-{alpha} on LC is largely independent from IL-1, we tested the converse, namely, whether IL-1 can induce corneal LC recruitment independently of TNF-{alpha} receptor function. Our data show that IL-1{alpha}-induced migration of corneal LC can be significantly impaired in the absence of TNF-RI, TNF-RII, or both receptors, suggesting that the well-known effect of IL-1 on early LC recruitment in the cornea after an inflammatory insult is at least in part mediated by TNF-{alpha}. Interestingly, 1 wk after injection of IL-1, there was no appreciable effect of either TNF-RI or TNF-RII deficiency on IL-1-induced LC migration, whereas the suppression of LC migration was still highly appreciable among the p55-/-p75-/- mice, suggesting some degree of functional redundancy between the two TNF receptor subtypes, or other compensatory mechanism, in animals devoid of just one type of TNFR. Hence, in the aggregate, the data suggest that while p55 and p75 play discrete roles in effecting corneal LC migration, there is likely also some functional redundancy between the two receptor systems.

It is important to emphasize the limitations of this study. First, our studies have focused exclusively on epithelial LC, since the vast majority of LC in both humans and rodents are in this layer of the cornea and limbus. Nevertheless, it is important to appreciate that there are a very few LC, based on morphological criteria, that can also be identified in the anterior stroma of the cornea subsequent to corneal stimulation. Whether the functional role or regulation of these cells differs from that of the large number of LC seen in the epithelium remains unknown. Second, it is critical to appreciate that while our data suggest a prominent role for TNF-{alpha} and IL-1 in effecting corneal LC migration, we caution that the data should not be taken as suggestions that these cytokines effect LC migration directly. It is known that the recruitment of leukocytic populations, including dendritic cells, relies on an intricate interaction between the activation of adhesion molecules (e.g., CD44) and chemoattractants (38). The critical role of TNF-{alpha} and IL-1 in regulating the expression of these adhesion and chemotactic factors in a large number of clinical and experimental settings is now widely appreciated (36). Since both of these proinflammatory cytokines are overexpressed early after an inflammatory insult, one may speculate that TNF-{alpha}-induced activation of nonlymphoid (e.g., resident corneal) cell NF-{kappa}B response elements can promote the expression of a wide array of chemokines (26, 27, 36) and adhesion factors that may themselves mediate LC migration (39, 40). A similar indirect role for TNF-{alpha} has been proposed as a possible mechanism in TNF-{alpha}-induced migration of cutaneous LC (41).

Lastly, it is important to recognize that the molecular processes that mediate corneal LC migration may differ from those that mediate LC migration elsewhere, as in the skin. In addition to the lack of a constitutive population of LC, the normal cornea unlike the skin is avascular and devoid of lymphatics. Moreover, intraepithelial (horizontal) migration of LC in the cornea differs considerably from that seen in the skin where the LC migrate into and out of the epidermis (vertically) via the dermis (3, 4, 5, 6, 7, 8). This factor may explain the relevance of p55 functionality in corneal LC migration, since p55 is the major from of TNFR expressed by keratocytic/epithelial populations (42). Hence, one may speculate that p55-mediated expression of epithelial chemotactic and adhesion factors can participate in effecting LC migration (42).

Molecular strategies designed to target selective mediators of inflammation have the potential of obviating some of the concerns shared in relation to local and systemic toxic side effects of nonspecific immunosuppression. One of the hurdles in development of these molecular strategies is the significant functional overlap that can exist among different ligands and receptor systems. The data presented herein suggest that while in fact both the IL-1 and TNF-{alpha} systems can induce corneal LC migration, the IL-1-mediated induction of the migration of these important APCs is largely dependent on the functional activity of the TNFR system. These findings merit further study in disease models as possible strategies to modulate immunoinflammatory responses in the cornea and ocular anterior segment.


    Footnotes
 
1 Supported by National Institutes of Health Grant EY00363 (M.R.D.) Eye Bank Association of America (M.R.D.), Fight for Sight (M.R.D.), and a Balokovic Scholarship from Harvard University (I.D.). Back

2 Address correspondence and reprint requests to Dr. M. Reza Dana, Laboratory of Immunology, Schepens Eye Research Institute, 20 Staniford Street, Boston, MA 02114. E-mail address: Back

3 Abbreviations used in this paper: LC, Langerhans cell; IL-1RI, IL-1 receptor type I; IL-1ra, IL-1 receptor antagonist; KO, knockout; TNF-{alpha}, tumor necrosis-{alpha}; TNFR, TNF receptor. Back

Received for publication July 30, 1998. Accepted for publication December 29, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Langerhans, P.. 1868. Ueber die Nerven der menschlichen haut. Virchows Arch. Pathol. Anat. Physiol. 44:325.
  2. Engelmann, T. W. 1910. Uber die Hornhaut des Auges (1867). In H. Graefe-Saemisch Handbuch der gesammten Augenheilkunde, 2nd Ed., Vol. 1. Leipzig, p. 30.
  3. Gillette, T. E., J. W. Chandler, J. V. Greiner. 1982. Langerhans cells of the ocular surface. Ophthalmology 89:700.[Medline]
  4. Jager, M. J., D. S. Gregerson, J. W. Streilein. 1995. Regulators of immunological responses in the cornea and the anterior chamber of the eye. Eye 9:241.
  5. Asbell, P. A., T. Kamenar. 1987. The response of Langerhans cells in the cornea to herpetic keratitis. Curr. Eye Res. 6:179.[Medline]
  6. Williamson, J. S. P., S. DiMarco, J. W. Streilein. 1987. Immunobiology of Langerhans cells on the ocular surface. Invest. Ophthalmol. Vis. Sci. 28:1527.[Abstract/Free Full Text]
  7. McLeish, W., P. Rubsamen, S. A. Atherton, J. W. Streilein. 1989. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice. Reg. Immunol. 2:236.[Medline]
  8. Miller, J. K., K. A. Laycock, M. M. Nash, J. S. Pepose. 1993. Corneal Langerhans cell dynamic after herpes simplex virus reactivation. Invest. Ophthalmol. Vis. Sci. 34:2282.[Abstract/Free Full Text]
  9. Niederkorn, J. Y.. 1995. Effects of cytokine-induced migration of Langerhans cells on corneal allograft survival. Eye 9:215.
  10. Sano, Y., B. R. Ksander, J. W. Streilein. 1996. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transplant. Immunol. 4:53.[Medline]
  11. Sano, Y., B. R. Ksander, J. W. Streilein. 1997. Murine orthotopic corneal transplantation in high-risk eyes: rejection is dictated primarily by weak rather than strong alloantigens. Invest. Ophthalmol. Vis. Sci. 38:1130.[Abstract/Free Full Text]
  12. Yamada, J., M. R. Dana, S. N. Zhu, P. Alard, J. W. Streilein. 1998. Interleukin-1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch. Ophthalmol. 116:1351.[Abstract/Free Full Text]
  13. Dana, M. R., J. Yamada, J. W. Streilein. 1997. Topical interleukin-1 receptor antagonist promotes corneal transplant survival. Transplantation 63:1501.[Medline]
  14. Dana, M. R., R. Dai, S. Zhu, J. Yamada, J. W. Streilein. 1998. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest. Ophthalmol. Vis. Sci. 39:70.[Abstract/Free Full Text]
  15. Jager, M. J., S. Atherton, D. Bradley, J. W. Streilein. 1991. Herpetic stromal keratitis in mice: less reversibility in the presence of Langerhans cells in the central cornea. Curr. Eye Res. 10:(Suppl.):69.
  16. Jager, M. J.. 1992. Corneal Langerhans cells and ocular immunology. Reg. Immunol. 4:186.[Medline]
  17. Hendricks, R. L., M. Janowicz, T. M. Tumpey. 1992. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 148:2522.[Abstract]
  18. Jager, M. J., D. Bradley, S. Atherton, J. W. Streilein. 1992. Presence of Langerhans cells in the central cornea linked to the development of ocular herpes in mice. Exp. Eye Res. 54:835.[Medline]
  19. Jager, M. J., D. S. Gregerson, J. W. Streilein. 1995. Regulators of immunological responses in the cornea and the anterior chamber of the eye. Eye 9:241.
  20. Gery, I., P. Davies, J. Derr, N. Krett, J. A. Barranger. 1981. Relationship between production and release of lymphocyte-activating factor (interleukin-1) by murine macrophages. Cell. Immunol. 64:293.[Medline]
  21. Niederkorn, J. Y., J. S. Peeler, J. Mellon. 1989. Phagocytosis of particulate antigens by corneal epithelial cells stimulate interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg. Immunol. 2:83.[Medline]
  22. Sekine-Okano, M., R. Lucas, D. Rungger, T. DeKesel, G. E. Grau, P. M. Leuenberger, E. Rungger-Brandle. 1996. Expression and release of tumor necrosis factor-{alpha} by explants of mouse cornea. Invest. Ophthalmol. Vis. Sci. 37:1302.[Abstract/Free Full Text]
  23. Cumberbatch, M., I. Kimber. 1995. Tumour necrosis factor-{alpha} is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31.[Medline]
  24. Wang, B., S. Kondo S, G. M. Shivji, H. Fugisawa. 1996. Tumour necrosis factor receptor II (p75) signaling is required for the migration of Langerhans’ cells. Immunology 88:284.[Medline]
  25. Cumberbatch, M., R. J. Dearman, I. Kimber. 1997. Langerhans cells require signals from both tumour necrosis factor-{alpha} and interleukin-1ß for migration. Immunology 92:388.[Medline]
  26. Le, J., J. Vilcek. 1987. Biology of disease: tumour necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest. 56:234.[Medline]
  27. Eigler, A., B. Sinha, G. Hartmann, S. Endres. 1997. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today 18:487.[Medline]
  28. Tartaglia, L. A., C. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendley, Jr M. A. Palladino. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.[Abstract]
  29. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943.[Abstract/Free Full Text]
  30. Rubsamen, P. E., J. P. McCulley, P. R. Bergstresser, J. W. Streilein. 1984. On the Ia immunogenicity of mouse corneal allografts infiltrated with Langerhans cells. Invest. Ophthalmol. Vis. Sci. 25:513.[Abstract/Free Full Text]
  31. Streilein, J. W., G. B. Toews, P. R. Bergstresser. 1979. Corneal allografts fail to express Ia antigens. Nature 282:326.[Medline]
  32. Peeler, J. S., J. Y. Niederkorn. 1986. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J. Immunol. 136:4362.[Abstract]
  33. Asbell, P. A., T. Kamenar, J. David. 1986. The response of Langerhans cells in the cornea to the herpetic keratitis. Invest. Ophthalmol. Vis. Sci. (Suppl.) 27:133.
  34. Kondo, S., D. N. Sauder. 1997. Tumor necrosis factor (TNF) receptor type I (p55) is a main mediator for TNF-{alpha}-induced skin inflammation. Eur. J. Immunol. 27:1713.[Medline]
  35. Taub, D. D., J. J. Openheim. 1994. Chemokines, inflammation and the immune system. Ther. Immunol. 1:229.[Medline]
  36. Luster, A. D.. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.[Free Full Text]
  37. Fukagawa, K., H. Saito, K. Tsubota, S. Shimmura, H. Tachimoto, A. Akasawa, Y. Oguchi. 1997. RANTES production in a conjunctival epithelial cell line. Cornea 16:564.[Medline]
  38. Weiss, J. M., J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxix, N. Howells, M. Hofmann, G. Kohler, E. Schopf, H. Ponta, P. Herrlich, J. C. Simon. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137.[Abstract/Free Full Text]
  39. Ma, J., J. H. Wang, Y. J. Guo, M. S. Sy, M. Bigby. 1994. In vitro treatment with anti-I-CAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell. Immunol. 158:389.[Medline]
  40. Tang, A., M. Amagai, L. G. Granger, J. R. Stanley, M. C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361:82.[Medline]
  41. Wang, B., H. Fujisawa, L. Zhuang, S. Kondo, G. M. Shivji, C. S. Kim, T. W. Mak, D. N. Sauder. 1997. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159:6148.[Abstract]
  42. Trefzer, U., M. Brockhaus, H. Loetscher, F. Partlow, A. Kapp, E. Schopf, J. Krutmann. 1991. 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J. Invest. Dermatol. 97:911.[Medline]



This article has been cited by other articles:


Home page
Arch OphthalmolHome page
S. Rashid, Y. Jin, T. Ecoiffier, S. Barabino, D. A. Schaumberg, and M. R. Dana
Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye
Arch Ophthalmol, February 1, 2008; 126(2): 219 - 225.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. R. Chinnery, M. J. Ruitenberg, G. W. Plant, E. Pearlman, S. Jung, and P. G. McMenamin
The Chemokine Receptor CX3CR1 Mediates Homing of MHC class II-Positive Cells to the Normal Mouse Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1568 - 1574.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. M. Chandrasekharan, M. Siemionow, M. Unsal, L. Yang, E. Poptic, J. Bohn, K. Ozer, Z. Zhou, P. H. Howe, M. Penn, et al.
Tumor necrosis factor {alpha} (TNF-{alpha}) receptor-II is required for TNF-{alpha}-induced leukocyte-endothelial interaction in vivo
Blood, March 1, 2007; 109(5): 1938 - 1944.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Yamagami, P. Hamrah, K. Miyamoto, D. Miyazaki, I. Dekaris, T. Dawson, B. Lu, C. Gerard, and M. R. Dana
CCR5 Chemokine Receptor Mediates Recruitment of MHC Class II-Positive Langerhans Cells in the Mouse Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1201 - 1207.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. R. Dana
Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727.
[Full Text] [PDF]


Home page
IOVSHome page
S. Wasmuth, D. Bauer, Y. Yang, K.-P. Steuhl, and A. Heiligenhaus
Topical Treatment with Antisense Oligonucleotides Targeting Tumor Necrosis Factor-{alpha} in Herpetic Stromal Keratitis
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5228 - 5234.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. CHEN, Q. KE, Y. YANG, J. S. RANA, J. TANG, J. P. MORGAN, and Y.-F. XIAO
Cardiomyocytes overexpressing TNF-{alpha} attract migration of embryonic stem cells via activation of p38 and c-Jun amino-terminal kinase
FASEB J, December 1, 2003; 17(15): 2231 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Hamrah, S. O. Huq, Y. Liu, Q. Zhang, and M. R. Dana
Corneal immunity is mediated by heterogeneous population of antigen-presenting cells
J. Leukoc. Biol., August 1, 2003; 74(2): 172 - 178.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
P. Hamrah, Y. Liu, Q. Zhang, and M. R. Dana
Alterations in Corneal Stromal Dendritic Cell Phenotype and Distribution in Inflammation
Arch Ophthalmol, August 1, 2003; 121(8): 1132 - 1140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Hamrah, L. Chen, Q. Zhang, and M. R. Dana
Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells
Am. J. Pathol., July 1, 2003; 163(1): 57 - 68.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Hamrah, Y. Liu, Q. Zhang, and M. R. Dana
The Corneal Stroma Is Endowed with a Significant Number of Resident Dendritic Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 581 - 589.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Nakae, Y. Komiyama, S. Narumi, K. Sudo, R. Horai, Y.-i. Tagawa, K. Sekikawa, K. Matsushima, M. Asano, and Y. Iwakura
IL-1-induced tumor necrosis factor-{alpha} elicits inflammatory cell infiltration in the skin by inducing IFN-{gamma}-inducible protein 10 in the elicitation phase of the contact hypersensitivity response
Int. Immunol., February 1, 2003; 15(2): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. S. Brissette-Storkus, S. M. Reynolds, A. J. Lepisto, and R. L. Hendricks
Identification of a Novel Macrophage Population in the Normal Mouse Corneal Stroma
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2264 - 2271.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Hamrah, Q. Zhang, Y. Liu, and M. R. Dana
Novel Characterization of MHC Class II-Negative Population of Resident Corneal Langerhans Cell-Type Dendritic Cells
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 639 - 646.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. Liu, P. Hamrah, Q. Zhang, A. W. Taylor, and M. R. Dana
Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II-positive Dendritic Cells Derived from MHC Class II-negative Grafts
J. Exp. Med., January 22, 2002; 195(2): 259 - 268.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Nakae, C. Naruse-Nakajima1, K. Sudo, R. Horai, M. Asano, and Y. Iwakura
IL-1{alpha}, but not IL-1{beta}, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity
Int. Immunol., December 1, 2001; 13(12): 1471 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Antonopoulos, M. Cumberbatch, R. J. Dearman, R. J. Daniel, I. Kimber, and R. W. Groves
Functional Caspase-1 Is Required for Langerhans Cell Migration and Optimal Contact Sensitization in Mice
J. Immunol., March 15, 2001; 166(6): 3672 - 3677.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Hori and J. W. Streilein
Role of Recipient Epithelium in Promoting Survival of Orthotopic Corneal Allografts in Mice
Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 720 - 726.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
Y. Qian, I. Dekaris, S. Yamagami, and M. R. Dana
Topical Soluble Tumor Necrosis Factor Receptor Type I Suppresses Ocular Chemokine Gene Expression and Rejection of Allogeneic Corneal Transplants
Arch Ophthalmol, December 1, 2000; 118(12): 1666 - 1671.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dekaris, I.
Right arrow Articles by Dana, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dekaris, I.
Right arrow Articles by Dana, M. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS